MTNB
Matinas BioPharma Holdings, Inc.
NYSE Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Net Income
$-10345000
↑ 57.3%
Revenue
$1.1M
0.0%
Operating Income
$-6960000
↑ 71.7%
EPS (Diluted)
$-2.00
↑ 59.8%
Total Assets
$7.2M
↓ 43.0%
Total Liabilities
$2.4M
↓ 52.9%
Shareholders' Equity
$4.8M
↓ 36.4%
Cash & Equivalents
$4.0M
↓ 45.1%

Recent SEC Filings

Form Type Filed Date Link
8-K 6/26/2026 View on SEC
424B7 6/22/2026 View on SEC
S-3 6/16/2026 View on SEC
10-Q 5/8/2026 View on SEC
8-K 4/3/2026 View on SEC
10-K 3/31/2026 View on SEC
8-K 1/23/2026 View on SEC
8-K 12/12/2025 View on SEC
8-K 11/21/2025 View on SEC
SCHEDULE 13G/A 11/14/2025 View on SEC

Company Information

Field Value
Ticker MTNB
Company Name Matinas BioPharma Holdings, Inc.
CIK 1582554
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange NYSE
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 908-484-8805